Ropivacaine Plus Magnesium Sulphate Infiltration
- Conditions
- Parathyroid DiseasesPostoperative PainAnesthesia, LocalThyroid Diseases
- Interventions
- Registration Number
- NCT05294393
- Lead Sponsor
- Aristotle University Of Thessaloniki
- Brief Summary
In the domain of endocrine gland surgery, thyroidectomy is the most common procedure. Patients report moderate to severe discomfort postoperatively, which is induced by a variety of mechanisms, the most common of which are cervical incision and surgical maneuvers. The other two causes are endotracheal intubation and neck overextension. Incisional pain, odynophagia, dysphagia, neck and shoulder pain have all been reported as sources of discomfort.However, it seems that this discomfort has a time limit, with a considerable decrease in pain scores that will last 24 to 36 hours. Pain is felt more profoundly within the first few hours after surgery, peaking at 6 hours, with patients requesting further analgesic medication.
Surgical wound infiltration can inhibit this procedure by preventing the alginate signal from reaching the incision site's receptors. According to the multimodal analgesia trends, magnesium sulfate can be added to the ropivacaine solution. Magnesium acts as an NMDA (N-methyl-D-aspartate) receptor antagonist, inhibiting cerebral sensitization to peripheral pain stimuli while reducing pre-existing hyperalgesia.
It becomes evident that this combination could contribute to attain the maximum analgesic efficacy. So, if any superiority of ropivacaine plus magnesium sulphate over ropivacaine could be demonstrated this would be very helpful in providing sufficient analgesic effects with a low incidence of adverse effects, while enhancing the option of one day surgery.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 68
- Patient ≥ 18 years old
- Surgical indication for Total thyroidectomy
- Surgical indication forparathyroidectomy
- Patients < 18 years old
- Prior neck operation
- Lateral neck dissection
- Patient with history of chronic opioid use
- Patient with chronic pain syndromes
- Patient with allergy to ropivacaine
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Ropivacaine 10% Ropivacaine 10% Wound infiltration with 12 ml solution of 100mg ropivacaine at the end of surgery before wound closure Ropivacaine 10% magnesium sulphate 10mg/kg Ropivacaine 10% plus magnesium sulphate 10mg/kg Wound infiltration with 12 ml solution of 100mg ropivacaine plus magnesium sulphate 10mg/kg at the end of surgery before wound closure
- Primary Outcome Measures
Name Time Method Efficacy of Ropivacaine Plus Magnesium Sulphate Infiltration vs Ropivacaine 24 postoperative hours Calculation of the total post-operative analgesic doses administered, converted to effective mg of morphine.
- Secondary Outcome Measures
Name Time Method Subjective measurements 2 30 minutes before the infiltration, 6 hours and 24 hours postoperatively Alterations in Tumor Necrosis Factor a (TNF-a) in pg/ml
Subjective measurements 3 30 minutes before the infiltration, 6 hours and 24 hours postoperatively Alterations in Interleukin 6 (IL-6) in pg/ml
Incisional Pain 30 minutes ,1 hour, 2 hours, 4 hours, 6 hours, 12 hours, 24 hours Incisional Pain will be measured by Visual Analogue Scale (VAS) pain questionnaire
Subjective measurements 1 30 minutes before the infiltration, 6 hours and 24 hours postoperatively Alterations in cortisol in μg/dl
Complications 24 hours, 7 days Adverse effects of the infiltrated agents
Trial Locations
- Locations (1)
Aristotle University
🇬🇷Thessaloniki, Other, Greece